Amgen settles with FTC over US$28 billion deal
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Sets price band at ?695 to ?735 per Equity Share
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Robots make it to the healthcare conference panel, reflecting the future potential of technology
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
Meningitis still affects more than 2.5 million people globally each year
Subscribe To Our Newsletter & Stay Updated